EI
AVXL icon

EFG International’s Anavex Life Sciences AVXL Stock Holding History

EFG International’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Buy
+700
New +$2.07K ﹤0.01% 1062

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EFG International's AVXL Position: Q2 2026 in Review

EFG International opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 700 shares worth $1.81K. The stake represents ﹤0.01% of the portfolio and ranks #1062 among its holdings.

178 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • EFG International held 700 shares of Anavex Life Sciences worth $1.81K as of Q2 2026.
  • Anavex Life Sciences was a new EFG International position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #1062 holding.
  • 178 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.